Page last updated: 2024-10-24

cefuroxime and Cardiac Failure

cefuroxime has been researched along with Cardiac Failure in 2 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research Excerpts

ExcerptRelevanceReference
"Digoxin is commonly prescribed to elderly patients with heart failure and atrial fibrillation, and macrolide antibiotics markedly increase the risk of digoxin toxicity."3.85Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study. ( Gomes, T; Huang, A; Juurlink, DN; Macdonald, EM; Mamdani, MM; Quinn, KL, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Quinn, KL1
Macdonald, EM1
Gomes, T1
Mamdani, MM1
Huang, A1
Juurlink, DN1
Petitpretz, P1
Choné, C1
Trémolières, F1

Trials

1 trial available for cefuroxime and Cardiac Failure

ArticleYear
Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval.
    International journal of antimicrobial agents, 2007, Volume: 30, Issue:1

    Topics: Aged; Bronchitis, Chronic; Cefuroxime; Female; Heart Failure; Humans; Levofloxacin; Male; Middle Age

2007

Other Studies

1 other study available for cefuroxime and Cardiac Failure

ArticleYear
Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study.
    Drug safety, 2017, Volume: 40, Issue:9

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Atrial Fibrillation; Azithromycin; Cardiotonic Agent

2017